Kenneth Galbraith
InvestorExecutive Partner of Syncona Investment Management Limited at Syncona · Chair & CEO at Zymeworks · Board director at Profound Medical
Cambridge, England, United Kingdom
Find your path to Kenneth
67 people in our graph share verified history with Kenneth — schools, employers, funds. One of them is your warm intro.
About
Kenneth Galbraith is an Executive Partner of Syncona Investment Management Limited, and in November 2024 was announced as joining the SIML Board and taking on the role of Chair (effective after regulatory approval). He has around 35 years of experience in biotechnology and venture capital, having served as CEO, CFO, Executive Chair, director, investor and advisor at both private and NASDAQ-listed companies across North America. He began his career in 1987 as CFO of QLT and currently serves as Chair and CEO of Zymeworks.
Invests in
BiotechMedical Devices
Chair & CEO at Zymeworks
Intro paths
In turn, Kenneth can intro founders to Zymeworks's investors below.
Zymeworks's investors · 5
Co-founders at Zymeworks
Executive at Zymeworks
Intro paths
In turn, Kenneth can intro founders to Zymeworks's investors below.
Zymeworks's investors · 5
Co-founders at Zymeworks
Board director at Profound Medical
Intro paths
In turn, Kenneth can intro founders to Profound Medical's investors below.
Experience
- SYNCONA INVESTMENT MANAGEMENT LIMITEDChaircurrent2025 — presentLondon Area, United Kingdom
- ZOMPDirectorcurrent2023 — presentCambridge, England, United Kingdom
- Zymeworks Inc.Chair and Chief Executive Officercurrent2022 — presentVancouver, British Columbia, Canada
- Syncona LimitedExecutive Partner2023 — 2025
- Kalium HealthExecutive Chair2021 — 2024Cambridge, England, United Kingdom
- Profound Medical Inc.Corporate Director2017 — 2023Mississauga, Ontario, Canada
- Syncona LimitedExecutive In Residence2021 — 2022London, England, United Kingdom
- Five Corners CapitalManaging Director2021 — 2022Cambridge, England, United Kingdom
- MacroGenics, Inc.Corporate Director2008 — 2022Rockville, Maryland, United States
- Liminal BioSciencesAdvisor2020 — 2021
- Liminal BioSciencesChief Executive Officer2019 — 2020Sawston, Cambridgeshire, United Kingdom
- PrometicChief Executive Officer2019Laval, Quebec, Canada
- Fairhaven Pharmaceuticals Inc.Chief Executive Officer2017 — 2019Canada
- Prometic BioProduction & BioTherapeuticsCorporate Director2016 — 2019Laval, Quebec, Canada
- Five Corners Capital Inc.Managing Director2013 — 2019White Rock
- Genesys Capital PartnersVenture Partner2013 — 2019Toronto, Ontario, Canada
- NeurAxon IncCorporate Director2008 — 2015Toronto, Ontario, Canada
- Tekmira PharmaceuticalsCorporate Director2010 — 2014Burnaby, British Columbia, Canada
- Genome British ColumbiaBoard Member2008 — 2014Vancouver, British Columbia, Canada
- TRACON PharmaceuticalsChairman Of The Board2011 — 2014San Diego, California, United States
- Genome BCCorporate Director2008 — 2014Vancouver, British Columbia, Canada
Skills & more
From Kenneth's professional profile.
Investments
Board seats
Kalium HealthZOMPZymeworks
Per the firm's website.
Colleagues at Syncona
Frequently asked questions
- Who is Kenneth Galbraith?
- Kenneth Galbraith is an Executive Partner of Syncona Investment Management Limited, and in November 2024 was announced as joining the SIML Board and taking on the role of Chair (effective after regulatory approval). He has around 35 years of experience in biotechnology and venture capital, having served as CEO, CFO, Executive Chair, director, investor and advisor at both private and NASDAQ-listed companies across North America. He began his career in 1987 as CFO of QLT and currently serves as Chair and CEO of Zymeworks.
- Where does Kenneth Galbraith work?
- Kenneth Galbraith is Executive Partner of Syncona Investment Management Limited at Syncona and Chair & CEO at Zymeworks and Executive at Zymeworks and Board director at Profound Medical.
- What does Kenneth Galbraith invest in?
- Kenneth Galbraith invests in Biotech, Medical Devices.
- What boards does Kenneth Galbraith sit on?
- Kenneth Galbraith holds tracked board seats at Kalium Health, ZOMP, Zymeworks.
- Where did Kenneth Galbraith go to school?
- Kenneth Galbraith studied at University of BC (B.Comm ( Honours)).
Founder mafias
Macrogenics Inc mafia2
Also came through, then founded or led a company.
Syncona mafia2
Also came through, then founded or led a company.
Shared employers
Also worked at Zymeworks Inc.7
+ 1 more
Also worked at Kalium Health2
Also worked at Profound Medical Inc.3
Also worked at MacroGenics, Inc.8
+ 2 more